Homburger advised CDR-Life in the transaction. CDR-Life Inc, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, announced the closing […]
CDR-Life Inc’s $76 Million Series A Financing Round
Sunrise UPC’s Strategic Partnership With CH Media
Homburger advised Sunrise UPC on the transaction. Pestalozzi advised CH Media. Sunrise UPC and CH Media have announced a long-term strategic partnership to drive the expansion […]
CSL’s A$16.4 Billion Acquisition of Vifor Pharma
Homburger AG, Bär & Karrer, Simpson Thacher & Bartlett LLP, and Allens acted as joint legal advisors to CSL. PJT Partners, BofA Securities and Goldman Sachs […]
Bergé Auto’s Acquisition of Nissan Distribution Business in Switzerland
Homburger advised Bergé Auto on the transaction, Binder Groesswang advised German Nissan Center Europe while Cerha Hempel advised Astara. Bergé Auto announced that it has reached […]
Bergé Auto’s Acquisition of Distribution Business of Abarth, Fiat, Alfa Romeo, Jeep and Fiat Professional Brands in Switzerland
Pestalozzi advised Stellantis on the deal, while Homburger advised Bergé Auto. Stellantis has agreed to sell FCA Switzerland SA to Bergé Auto with Bergé Auto taking […]
Roche Holding’s CHF19 Billion Bridge Financing Agreement
Baker McKenzie advised BNP Paribas and Deutsche Bank on the deal. Lenz & Staehelin acted as legal advisor to the Roche family pool. Bär & Karrer […]
Archlet’s $10 Million Series A Financing Round
Homburger advised HV Capital on the deal. Wenger Vieli advised Archlet. Archlet AG, a spin-off of ETH Zurich that develops and markets data-driven sourcing software, announced […]
anthera Pharmaceuticals’ CHF 15 Million Private Convertible Bonds And CHF 10 Million Exchangeable Notes
Homburger advised Santhera in this matter. Santhera Pharmaceuticals annouced a strengthening of its capital structure via placement of private convertible bonds of CHF 15 million and upsizing of […]
ADC Therapeutics’ $325 Million Royalty Purchase Agreement With HealthCare Royalty
Homburger advised ADC Therapeutics SA on the agreement. ADC Therapeutics SA (NYSE: ADCT), a Swiss-based commercial-stage oncology-focused biotechnology company, announced that it had entered into a […]
Santhera Pharmaceuticals’ CHF 20 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular […]
Glatfelter Corp.’s DKK 2 Billion Acquisition of Jacob Holm & Sønner
Accura advised Mikkelsen family in connection with the transaction. Homburger advised Glatfelter. Shearman & Sterling advised Glatfelter. The Danish company Jacob Holm & Sønner has been […]
SOPHiA GENETICS’ $234 Million Initial Public Offering on Nasdaq
Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares […]